Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatitis d.
Koytak ES, Yurdaydin C, Glenn JS. Koytak ES, et al. Among authors: yurdaydin c. Curr Treat Options Gastroenterol. 2007 Dec;10(6):456-63. doi: 10.1007/s11938-007-0045-8. Curr Treat Options Gastroenterol. 2007. PMID: 18221606
Lichen planus and HCV infection in Turkish patients.
Karavelioğlu D, Koytak ES, Bozkaya H, Uzunalimoğlu O, Bozdayi AM, Yurdaydin C. Karavelioğlu D, et al. Among authors: yurdaydin c. Turk J Gastroenterol. 2004 Sep;15(3):133-6. Turk J Gastroenterol. 2004. PMID: 15492909 Free article.
PPAR-alpha L162V polymorphism in human hepatocellular carcinoma.
Koytak ES, Mizrak D, Bektaş M, Verdi H, Arslan Ergül A, Idilman R, Cinar K, Yurdaydin C, Ersõz S, Karayalçin K, Uzunalimoğlu O, Bozkaya H. Koytak ES, et al. Among authors: yurdaydin c. Turk J Gastroenterol. 2008 Dec;19(4):245-9. Turk J Gastroenterol. 2008. PMID: 19119483 Free article.
Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction.
Nishimura T, Hu Y, Wu M, Pham E, Suemizu H, Elazar M, Liu M, Idilman R, Yurdaydin C, Angus P, Stedman C, Murphy B, Glenn J, Nakamura M, Nomura T, Chen Y, Zheng M, Fitch WL, Peltz G. Nishimura T, et al. Among authors: yurdaydin c. J Pharmacol Exp Ther. 2013 Feb;344(2):388-96. doi: 10.1124/jpet.112.198697. Epub 2012 Nov 8. J Pharmacol Exp Ther. 2013. PMID: 23143674 Free PMC article.
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.
Koh C, Canini L, Dahari H, Zhao X, Uprichard SL, Haynes-Williams V, Winters MA, Subramanya G, Cooper SL, Pinto P, Wolff EF, Bishop R, Ai Thanda Han M, Cotler SJ, Kleiner DE, Keskin O, Idilman R, Yurdaydin C, Glenn JS, Heller T. Koh C, et al. Among authors: yurdaydin c. Lancet Infect Dis. 2015 Oct;15(10):1167-1174. doi: 10.1016/S1473-3099(15)00074-2. Epub 2015 Jul 16. Lancet Infect Dis. 2015. PMID: 26189433 Free PMC article. Clinical Trial.
Therapy of Delta Hepatitis.
Yurdaydin C, Idilman R. Yurdaydin C, et al. Cold Spring Harb Perspect Med. 2015 Aug 7;5(10):a021543. doi: 10.1101/cshperspect.a021543. Cold Spring Harb Perspect Med. 2015. PMID: 26253093 Free PMC article. Review.
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy.
Yurdaydin C, Abbas Z, Buti M, Cornberg M, Esteban R, Etzion O, Gane EJ, Gish RG, Glenn JS, Hamid S, Heller T, Koh C, Lampertico P, Lurie Y, Manns M, Parana R, Rizzetto M, Urban S, Wedemeyer H; Hepatitis Delta International Network (HDIN). Yurdaydin C, et al. J Hepatol. 2019 May;70(5):1008-1015. doi: 10.1016/j.jhep.2018.12.022. Epub 2018 Dec 27. J Hepatol. 2019. PMID: 30982526 Review.
188 results